Drreddys Laboratories | RDY - Net Income


Drreddys Laboratories reported INR12.1B in Net Income for its fiscal quarter ending in December of 2025.





Net Income Change Date
ANI Pharmaceuticals USD 26.27M 18.13M Sep/2025
Aurora Cannabis CAD -51.47M 36.26M Sep/2025
Bayer EUR -963M 764M Sep/2025
Canopy Growth CAD -1.64M 39.89M Sep/2025
Cipla INR 6.76B 6.75B Dec/2025
Corcept Therapeutics USD 19.67M 15.48M Sep/2025
Drreddys Laboratories INR 12.1B 2.08B Dec/2025
GlaxoSmithKline GBP 2.01B 570M Sep/2025
Hikma Pharmaceutical USD 119M 14M Jun/2025
Lonza CHF 307M 22M Dec/2024
Novartis USD 3.93B 96M Sep/2025
Pacira USD 5.43M 10.28M Sep/2025
Prestige Brands USD 69.13M 7.36M Sep/2025
Richter Gedeon HUF 43.35B 6.29B Sep/2025
Sun Pharmaceuticals INR 33.69B 2.51B Dec/2025
Supernus Pharmaceuticals USD -45.12M 67.62M Sep/2025
Teva Pharmaceutical Industries USD 480M 47M Dec/2025